Literature DB >> 1919887

Reduced plasma C-20 and C-22 polyunsaturated fatty acids in children with phenylketonuria during dietary intervention.

C Galli1, C Agostoni, C Mosconi, E Riva, P C Salari, M Giovannini.   

Abstract

The fatty acid composition of plasma and erythrocyte lipids was analyzed in 15 children with phenylketonuria (aged 3 to 12 years) during dietary treatment aimed to maintain plasma phenylalanine levels at less than 8 mg/dl (485 mumol/L), and compared with those of 12 matched control subjects. The diet of children with phenylketonuria provided less protein, with a very low proportion of animal proteins, less fat, but a higher proportion of linoleic acid as a percentage of calories, and a higher carbohydrate content versus that in the diet of control subjects. The children with phenylketonuria had higher plasma levels of oleic acid but lower levels of arachidonic (n-6) and n-3 fatty acids. Linoleic and eicosatrienoic (n-9) acid levels were the same in both groups. These changes in patients with phenylketonuria resemble those observed in vegetarians and may be due to the absence of preformed arachidonic acid and long-chain n-3 fatty acids in the phenylketonuric diet.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1919887     DOI: 10.1016/s0022-3476(05)82405-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  23 in total

1.  A randomized, placebo-controlled, double-blind trial of supplemental docosahexaenoic acid on cognitive processing speed and executive function in females of reproductive age with phenylketonuria: A pilot study.

Authors:  S H L Yi; J A Kable; M L Evatt; R H Singh
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2011-10-14       Impact factor: 4.006

Review 2.  Somatic gene therapy for phenylketonuria and other hepatic deficiencies.

Authors:  R C Eisensmith; S L Woo
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

3.  Docosahexaenoic acid status in females of reproductive age with maple syrup urine disease.

Authors:  Laura M Mazer; Sarah H L Yi; Rani H Singh
Journal:  J Inherit Metab Dis       Date:  2010-03-09       Impact factor: 4.982

Review 4.  Lipid status and fatty acid metabolism in phenylketonuria.

Authors:  M Giovannini; G Biasucci; C Agostoni; D Luotti; E Riva
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

5.  PKU-related dysgammaglobulinaemia: the effect of diet therapy on IgE and allergic sensitization.

Authors:  E Riva; A Fiocchi; C Agostoni; G Biasucci; M Sala; G Banderali; D Luotti; M Giovannini
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

6.  Polyunsaturated fatty acid status in patients with phenylketonuria.

Authors:  P Sanjurjo; L Perteagudo; J Rodríguez Soriano; A Vilaseca; J Campistol
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

7.  NORMAL FATTY ACID CONCENTRATIONS IN YOUNG CHILDREN WITH PHENYLKETONURIA (PKU).

Authors:  Stacey M Lavoie; Cary O Harding; Melanie B Gillingham
Journal:  Top Clin Nutr       Date:  2009-10-01       Impact factor: 0.508

8.  Long-chain polyunsaturated fatty acids in plasma and erythrocyte membrane lipids of children with phenylketonuria after controlled linoleic acid intake.

Authors:  A P Pöge; K Bäumann; E Müller; M Leichsenring; H Schmidt; H J Bremer
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

9.  Recommendations for protein and amino acid intake in phenylketonuric patients.

Authors:  F Cockburn; B J Clark
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

10.  Fatty acid metabolism in phenylketonuria.

Authors:  M Giovannini; C Agostoni; G Biasucci; A Rottoli; D Luotti; S Trojan; E Riva
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.